Sentences with phrase «on diabetes patients»

«I believe his work will have a great impact on diabetes patients» health and quality of life.»

Not exact matches

Sanofi, a diabetes specialist which is now facing increased competition from rivals, has been on a mission to boost its treatment pipeline with new products for diseases that affect a wide swath of patients.

On the heels of rival diabetes drug maker Novo Nordisk's announcement that it will limit branded drug price hikes to the single digits going forward, U.S. pharma giant Eli Lilly announced Tuesday that it is partnering with benefits manager Express Scripts and a mobile health platform hosted by Blink Health to slash patients» insulin costs.

So the focus on gut, depression, diabetes, and these other drugs was done with the U.S. patient pool in mind?

An early, outsourced clinical research study with real patients was encouraging, but there are many potential pitfalls yet to come, said University of North Carolina diabetes researcher Dr. John Buse, who was briefed by Google on the lens last week.

Those prices take a toll on patients like 21 - year - old Hunter Sego, who needs about four vials a month for his Type 1 diabetes.

Mannkind, which focuses on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension, entered a shallow but persistent downtrend in 2004, posting a series of lower highs into 2015.

NextWave envisions a test where patients could place the sensor on their tongue to get readings on blood oxygen, blood glucose and uric acid — potential indicators of diabetes and gout.

They are especially focused on those with chronic conditions, like diabetes patients who need regular blood sugar monitoring.

Meet Omada Health: With 87M consumers at risk of diabetes, 75,000 patients treated, 3 years of outcomes data, NetPromoter scores in the 90's, 70 + clients, and looming reimbursement by Medicare for its diabetes prevention online social network, Omada has «cracked the code» on integrating consumer technology, medical coaching and big data at scale.

He has published seminal works on blood pressure management through his role in the BPLTTC and played leading roles in a series of trials that define the clinical management of patients with diabetes and chronic kidney disease.

Caribbean Life article on Borough President Adams commemorating Diabetes Awareness Day at Rogosin Institute — Brooklyn East in East New York, donating crocheted blankets, scarves, and socks to dialysis patients across the borough.

The Golden Goose Award has honored innovative research that developed a diabetes medication from Gila monster venom, an algorithm based on marriage stability that led to the development of a program to match kidney patients with donors and the «marshmallow test» — a measure of young children's self - control that has led to greater understanding of human behavior.

Researchers looked at data on 74 300 patient who received metformin and sulfonylurea, another common diabetes drug, over a 25 - year study period.

To date, no systematic review has compared the direct and indirect effects of these three different training modalities on the outcomes of blood sugar control and blood fats in patients with type 2 diabetes.

To investigate, researchers led by Roberto Pisoni, MD (Medical University of South Carolina) analyzed information on 56 patients with diabetes and CKD who had undergone screening for obstructive sleep apnea through the use of a questionnaire.

In patients with type 2 diabetes (T2D), a metabolic dysfunction prevents insulin from working on the liver.

The aim of the present study was to assess the efficacy of aerobic exercise training (AET), resistance training (RT) and combined training (CT) on blood sugar control, blood pressure and blood fats in patients with type 2 diabetes in a systematic review and meta - analysis.

In other words, patients with 20 percent BSA were at almost an 84 percent higher risk of developing type 2 diabetes, patients with 30 percent BSA were at a 104 percent higher risk, and so on.

Piggybacking on traditional diabetes technology, the PDH sends the patient's health information via modem or broadband connection to a central server every night, where InterMed's software analyzes it and produces a personalized feedback report, which is then e-mailed to the patient and care provider.

This is important as increased subfascial fat in patients with type 2 diabetes has been associated with insulin resistance, so reducing it could have a beneficial effect on glucose metabolism.

A 2003 study on Pakistani patients with poorly controlled diabetes showed that cinnamon reduced glucose and cholesterol levels.

«I put emphasis on a lot of counseling, following through with medications, educating the patient on things like learning how to use a diabetes meter, for instance.»

Counsel patients with or at high risk for high blood pressure, diabetes, or cancer on weight control and diet.

By combining data on optometry patient's eyes with advanced computational methods, Indiana University researchers have created a virtual tissue model of diabetes in the eye.

Medical scientists, on the other hand, are crunching billions of data points culled from millions of patients about genetic mutations that make people more vulnerable to diseases like diabetes, heart disease and cancer.

One in four patients develop heart failure within four years of a first heart attack, according to a study in nearly 25,000 patients presented today at Heart Failure 2016 and the 3rd World Congress on Acute Heart Failure by Dr Johannes Gho, a cardiology resident at the University Medical Center Utrecht, in Utrecht, the Netherlands.1 Risk factors included older age, greater socioeconomic deprivation, and comorbidities such as diabetes.

As an endocrinologist, I specialize in the management of hormonal disorders, and this is business as usual for me: More than 60 percent of my patient visits focus on diabetes.

More than half of this economic cost (56 %, $ 10.8 billion) was on accessing diabetes treatment, including medication and hospital stays — and one half of these costs were out - of - pocket (paid for by the patients), putting a huge financial burden on people with diabetes.

The Mayo task force does not recommend in favor of or against the use of statins in patients with diabetes in whom the risk for heart attacks or stroke is low based on the calculator proposed by the ACC / AHA.

«It was the first time in the history of diabetes that patients were on nothing after one treatment,» he says.

A new study by researchers from the University of Chicago Medicine, based on a 6 - month clinical trial, finds that use of a CGM is cost - effective for adult patients with type 1 diabetes when compared to daily use of test strips.

A growing body of evidence suggests that rapid detection of, and aggressive new therapies for, type - 1 diabetes benefit patients in the long run, possibly halting the autoimmune attack on the pancreas and preserving some of the body's ability to make insulin.

«The findings suggest that increasing dietary intake of polyunsaturated fats may have a beneficial effect for patients with a certain type of prediabetes but also illuminates why certain dietary changes may have no effect on progression of type 2 diabetes in the other subtype.

To date, diabetes treatment strategies are based on patients either injecting insulin, taking medicine to make their body more sensitive to insulin, or taking other drugs to stimulate insulin secretion.

Patients with JIA before Type 1 diabetes developed their diabetes on average nearly three years after the onset of JIA.

Called stereotactic body radiotherapy (SBRT), the study finds patients lived, on average, six to seven months longer following treatment with minimal side - effects even when they had other severe comorbidities such as chronic obstructive pulmonary disease (COPD), heart disease and diabetes.

The research team is doing further investigations various aspects of gait and how diabetes and DPN affects how these patients walk on level ground and on stairs, to identify and further understand factors that may contribute to unsteadiness and in turn the increased risk of falls.

But not much is known about the corresponding impact of bariatric surgery on mildly obese patients who have diabetes.

«Although in 2010, the International Diabetes Federation recommended surgery for diabetic patients with mild obesity if clinical treatment is not successful, few related studies on this topic have been published,» Soggia said.

Reducing the high type 1 diabetes mortality rates will need additional expenditure on the care of patients with the disorder, many of the benefits from which might not be seen for up to 20 years.

Every year, NIH research on cancer, heart disease, stroke, and diabetes alone averts up to 1.35 million deaths annually while providing hope to millions of patients and their families.

The blood pressure medication angiotensin - converting enzyme inhibitors (ACEIs) appear to reduce major cardiovascular events and death, as well death from all other causes, in patients with diabetes, while angiotensin II receptor blockers (ARBs) appear to have no such effect on those outcomes.

This recommendation was based on the ability of screening to identify persons with diabetes and evidence that more - intensive blood pressure treatment was associated with reduced risk for cardiovascular events, including cardiovascular mortality, in patients with diabetes and hypertension.

Providers decide upon pharmacological approaches based on numerous factors, the foremost of which is the extent to which the patient's diabetes is controlled.

«Many obese patients are on medication for chronic conditions such as heart disease, high blood pressure, high cholesterol, depression and diabetes,» says Chand.

Four - in - 10 patients were taking insulin injections and 60 percent were on oral medications for their diabetes before surgery.

BLOOMINGTON, Ind. — By combining data on optometry patients» eyes with advanced computational methods, Indiana University researchers have created a virtual tissue model of diabetes in the eye.

Screening patients for diabetes based solely on their age and weight — a recommendation from a leading medical expert group — could miss more than half of high - risk patients, according to a new Northwestern Medicine study...

According to Dr. McCoy, «This means that 3 out of 100 older or clinically complex patients with diabetes who never had hypoglycemia before, whose HbA1C is within recommended targets, and who are not on insulin, will experience a severe hypoglycemic episode at some point over two years.»